Top k-NN clusters of metabolites decreased at 4 hours. by Zarazuela Zolkipli-Cunningham (5234186)

Top k-NN cluster of metabolites decreased at 30 minutes. by Zarazuela Zolkipli-Cunningham (5234186)

The decrease in blood flow disrupts CV pruning. by Lin Wen (557398)

Effect of MI to decrease depressive symptoms (fixed-effects model). by Kalayou Kidanu Berhe (9557751)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Subjects:

Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response. by Marc Swidergall (185453)

Decrease in apoptosis in the ischemic myocardium. by Laura A. Scrimgeour (9367459)

“…<p>There is an increase seen in JNK, pBAD, and pBAD/BAD with a decrease in pBCL-2, pBCL-2/BCL-2, and Caspase 3. …”

TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. by Hannah C. Kubinski (21213168)

FTY720 treatment decreased phosphorylation of AKT, ERK, and c-myc. by Laura L. Stafman (6577184)

Subjects:

mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

“…<p>(<b>A</b>) Primary cultured podocytes were isolated from <i>Tsc2</i>^{Δ<i>podocyte</i>} and wild-type controls, followed by western blot analyses of TSC2, phospho-4EBP1, LC3B type II, p62, phospho-ULK1, and β-tubulin. …”

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. by Will Campodonico (20485651)

Subjects:

Decreased protection of NMT in <i>ACBD6</i>-deficient cells. by Eric Soupene (64584)

ILC2s decrease in blood but remain the same in adipose tissue. by Fred R. Sattler (9338330)

“…<p>In the sitagliptin-treated participants, changes in the ILCs in peripheral blood mononuclear cell (PBMC) fractions often were not congruent with the change or lack of change in the same cell lines in abdominal adipose tissue (data not shown). Panel A exemplifies a decrease in ILC-2 in PBMCs from a participant before and after 28 days of treatment with sitagliptin, respectively. …”

A randomized trial of a behavioral intervention to decrease hospital length of stay by decreasing bedrest by Juliana Tolles (8282265)

“…</p><p>Trial registration</p><p>ClinicalTrials.gov, <a href="https://clinicaltrials.gov/ct2/show/NCT04006990" target="_blank">HS-16-00804</a>.…”

Ammonia (NH₃) measurement (ppm) on the last day of a cage-change cycle in the front, middle and rear of the cage, for each site and sex. by B. Ulfhake (6293984)

Subjects:

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

Subjects: